Manipulation of tissue of organ type using the notch pathway

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S455000, C530S358000, C536S024100, C536S024500

Reexamination Certificate

active

08084258

ABSTRACT:
The present invention is directed to methods for altering the fate of a cell, tissue or organ type by altering Notch pathway function in the cell. The invention is further directed to methods for altering the fate of a cell, tissue or organ type by simultaneously changing the activation state of the Notch pathway and one or more cell fate control gene pathways. The invention can be utilized for cells of any differentiation state. The resulting cells may be expanded and used in cell replacement therapy to repopulate lost cell populations and help in the regeneration of diseased and/or injured tissues. The resulting cell populations can also be made recombinant and used for gene therapy or as tissue/organ models for research. The invention is directed to methods for of treating macular degeneration comprising altering Notch pathway function in retinal pigment epithelium cells or retinal neuroepithelium or both tissues. The present invention is also directed to kits utilizing the methods of the invention to generate cells, tissues or organs of altered fates. The invention also provides methods for screening for agonists or antagonists of Notch or cell fate control gene pathway functions.

REFERENCES:
patent: 5115096 (1992-05-01), Shoyab et al.
patent: 5132212 (1992-07-01), Kirsch et al.
patent: 5226914 (1993-07-01), Caplan et al.
patent: 5264557 (1993-11-01), Salomon et al.
patent: 5635177 (1997-06-01), Bennett et al.
patent: 5648464 (1997-07-01), Artavanis-Tsakonas et al.
patent: 5780300 (1998-07-01), Artavanis-Tsakonas et al.
patent: 5786158 (1998-07-01), Artavanis-Tsakonas et al.
patent: 5789195 (1998-08-01), Artavanis-Tsakonas et al.
patent: 5849869 (1998-12-01), Artavanis-Tsakonas et al.
patent: 5856441 (1999-01-01), Artavanis-Tsakonas et al.
patent: 5869282 (1999-02-01), Ish-Horowicz et al.
patent: 6004924 (1999-12-01), Ish-Horowicz et al.
patent: 6083904 (2000-07-01), Artavanis-Tsakonas et al.
patent: 6149902 (2000-11-01), Artavanis-Tsakonas et al.
patent: 6262025 (2001-07-01), Ish-Horowicz et al.
patent: 6337387 (2002-01-01), Sakano et al.
patent: 6436650 (2002-08-01), Artavanis-Tsakonas et al.
patent: 6692919 (2004-02-01), Artavanis-Tsakonas et al.
patent: 6783956 (2004-08-01), Ish-Horowicz et al.
patent: 7118890 (2006-10-01), Ish-Horowicz et al.
patent: 2004/0058443 (2004-03-01), Artavanis-Tsakonas et al.
patent: 2005/0112121 (2005-05-01), Artavanis-Tsakonas et al.
patent: 2007/0003983 (2007-01-01), Artavanis-Tsakonas et al.
patent: 2007/0082846 (2007-04-01), Ish-Horowicz et al.
patent: 2007/0134239 (2007-06-01), Ish-Horowicz et al.
patent: WO 92/19734 (1992-11-01), None
patent: WO 94/07474 (1994-04-01), None
patent: WO 94/13701 (1994-06-01), None
patent: WO95/027062 (1995-10-01), None
patent: WO 98/48829 (1998-11-01), None
Blaumueller et al., Cell, vol. 90, 1997, pp. 281-291.
Fleming et al., Trends in Cell Biology, vol. 7, 1997, pp. 437-441.
Branch, TIBS, vol. 23 (1998) pp. 45-50.
U.S. Appl. No. 10/746,237, filed Jul. 21, 2005, Artavanis-Tsakonas et al.
U.S. Appl. No. 11/605,536, filed Jul. 19, 2007, Artavanis-Tsakonas et al.
Ahmad et al., 1995, “Involvement of Notch-1 in mammalian retinal neurogenesis: association of Notch-1 activity with both immature and terminally differentiated cells.” Mech Dev. 53(1):73-85.
Artavanis-Tsakonas et al., 1999, “Notch signaling: cell fate control and signal integration in development”, Science 284:770-776.
Campos-Ortega et al., 1990, “Molecular analysis of a cellular decision during embryonic development of Drosophila melanogaster: epidermogenesis or neurogenesis.” Eur J Biochem. 190(1):1-10.
Czerny et al., 1999, “Twin of eyeless, a second Pax-6 gene of Drosophila, acts upstream of eyeless in the control of eye development”, Mol. Cell 3:297-307.
de Celis et al., 1993, “Genetic and molecular characterization of a Notch mutation in its Delta- and Serrate-binding domain in Drosophila.” Proc Natl Acad Sci U S A. 90(9):4037-41.
Eggert et al., 1998, “Isolation of a Drosophila homolog of the vertebrate homeobox gene Rx and its possible role in brain and eye development”, Proc. Natl. Acad. Sci. USA, 5:2343-48.
Ellisen et al., 1991, “TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.” Cell. 66(4):649-61.
Fleming et al., 1997, “The NOTCH receptor and its ligands.” Trends Cell Biol. 7(11): 437-441.
Fortini et al., 1992, “Signalling by the sevenless protein tyrosine kinase is mimicked by Ras1 activation.”Nature. 355(6360):559-61.
Fortini et al., 1993, “An activated Notch receptor blocks cell-fate commitment in the developing Drosophila eye”, Nature 365:555-57.
Go et al., 1998, “Cell proliferation control by Notch signaling in Drosophila development”, Development 125:2031-40.
Greenspan, 1990, “The Notch gene, adhesion, and developmental fate in the Drosophila embryo.” New Biol. 2(7):595-600.
Greenwald, 1994, “Structure/function studies of lin-12/Notch proteins”, Curr Opin Genet Dev. 4:556-62.
Halder et al., 1995, “Induction of Ectopic Eyes by Targeted Expression of the eyeless Gene in Drosophila”, Science 267:1788-92.
Hukriede et al., 1997, “A dominant-negative form of Serrate acts as a general antagonist of Notch activation”, Development 124(7):3427-37.
Nusse et al., 1992, “Wnt genes.” Cell. 69(7):1073-87.
Quiring et al., 1994, “Homology of the eyeless gene of Drosophila to the Small eye gene in mice and Aniridia in humans”, Science 265:785-9.
Rebay et al., 1991, Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell. 67(4):687-99.
Robbins et al., 1992, “Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells.” J Virol. 66(4):2594-9.
Roehl et al., 1993, “Control of cell fate in C. elegans by a GLP-1 peptide consisting primarily of ankyrin repeats.” Nature 364:632-5.
Struhl et al. 1993, “Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo.” Cell. 74(2):331-45.
Sun et al., 1997, “Evolution of paired domains: isolation and sequencing of jellyfish and hydra Pax genes related to Pax-5 and Pax-6.” Proc. Natl. Acad. Sci. USA 94:5156-5161.
Sun and Artavanis-Tsakonas, 1997, “Secreted forms of DELTA and SERRATE define antagonists of Notch signaling in Drosophila.” Development 124:3439-48.
Sun et al., 1996, “The intracellular deletions of DELTA and SERRATE define dominant negative forms of the Drosophila Notch ligands.” Development 122:2465-2474.
Artavanis-Tsakonas and Simpson, 1991, “Choosing a cell fate: a view from the Notch locus.” Trends in Genetics 7:403-408.
Artavanis-Tsakonas et al., 1991, “The Notch locus and the cell biology of neuroblast segregation.” Ann. Rev. Cell Biol. 7:427-452.
Artavanis-Tsakonas et al., 1995, “Notch signaling.” Science 268:225-232.
Berezovska et al., 1999, “Notch 1 inhibits neurite outgrowth in postmitotic primary neurons.” Neuroscience 93(2):433-439.
Briend et al., 2005, “Modulation of the notch pathway for immunotherapy.” Curr. Opin. Mol. Therapeutics 7(1):56-61.
Büchler et al., 2005, “The Notch signaling pathway is related to neurovascular progression of pancreatic cancer” Ann. Surg. 242:791.
Chigurupati et al., 2007, “Involvement of notch signaling in wound healing.” PloS ONE 2(11):e1167.
Coffman et al., 1990, “Xotch, the Xenopus homolog of Drosophila notch.” Science 249:1438-1441.
Dang et al., 2003, “Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.” Oncogene 22:1988.
Decision to Refuse a European Patent Application, from EP Application No. 99933914.3-2107, dated May 3, 2007.
Dontu et al., 2004, ȁ

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Manipulation of tissue of organ type using the notch pathway does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Manipulation of tissue of organ type using the notch pathway, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Manipulation of tissue of organ type using the notch pathway will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4268591

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.